of intraventricular and intravenous N,N',N" -triethylenethiophosphoramide (thiotepa) yol. 40, No.3, 1990: To accurately reflect the data presented in the main body of the text the following amendments to the Summary of teicoplanin should be noted: Page 450: Since most patients were also receiving aminoglycosides, the last sentence of the second paragraph of the synopsis should finish with ' ... are maintained, and concomitant administration of aminoglycosides makes causality difficult to assess.' Page 451: The final sentence of the third paragraph should end ' ... that teicoplanin may be primarily bacteriostatic against enterococci. '
